PMDA — authorised 4 April 2001
- Marketing authorisation holder: Mitsubishi Tanabe Pharma Corporation
- Status: approved
🇯🇵 Radicava in Japan
PMDA authorised Radicava on 4 April 2001
Marketing authorisation
Radicava in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Japan
Frequently asked questions
Is Radicava approved in Japan?
Yes. PMDA authorised it on 4 April 2001.
Who is the marketing authorisation holder for Radicava in Japan?
Mitsubishi Tanabe Pharma Corporation holds the Japanese marketing authorisation.